⌘K

Login Start Free

Home/Filings/4/0001125282-03-005256

4//SEC Filing

GOFF STEPHEN P 4

Accession 0001125282-03-005256

CIK 0000835887other

View on SEC.gov Company Profile

Filed

Sep 10, 8:00 PM ET

Accepted

Sep 11, 7:04 PM ET

Size

7.1 KB

Accession

0001125282-03-005256

Insider Transaction Report

Form 4

Period: 2003-04-01

PROGENICS PHARMACEUTICALS INCPGNX

Director

Transactions

Award
Stock Option (Right to Buy)
2003-07-01+10,000→ 10,000 total
Exercise: $15.06From: 2003-07-01Exp: 2013-06-30→ Common Stock (10,000 underlying)
Award
Stock Option (Right to Buy)
2003-04-01+2,500→ 2,500 total
Exercise: $4.41From: 2003-04-01Exp: 2013-03-31→ Common Stock (2,500 underlying)

Holdings

Common Stock, par value $0.0013 per share ("Common Stock")
33,500

Documents

1 file

4
b327073_ex.xmlPrimary
4

Issuer

PROGENICS PHARMACEUTICALS INC

CIK 0000835887

Entity typeother

Related Parties

1

filerCIK 0001250270

Filing Metadata

Form type: 4
Filed: Sep 10, 8:00 PM ET
Accepted: Sep 11, 7:04 PM ET
Size: 7.1 KB

View on SEC.gov